Since the key-role of VEGFA in vimentin expression promoting EMT changes [50] and chemoresistance [51] in BC cells, VEGFA overexpression may be partially responsible for the acquisition of the EMT phenotype and drug resistance found in CPS-treated BC cells. This evidence concerns the gene VIM and breast cancer.